The rise of digital direct-to-consumer advertising?: Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications Utilization, expenditure, economics and financing systems

BMC Health Services Research

Volumn 15, Issue 1, 2015, Pages

  Mackey, Tim K ^a,b,c   Cuomo, Raphael E ^c   Liang, Bryan A ^c  

^a University of California at San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Conflicts of interest; Direct to consumer advertising; eHealth; Health marketing and promotion; Health policy; Physician payments; Sunshine act

Indexed keywords

COMPARATIVE STUDY; DIRECT-TO-CONSUMER ADVERTIZING; ECONOMICS; FORECASTING; HUMAN; INTERNET; MARKETING; MASS MEDIUM; NEW ZEALAND; PROCEDURES; RADIO; STATISTICS AND NUMERICAL DATA; TELEVISION; TRENDS; UNITED STATES; UTILIZATION;

DIRECT-TO-CONSUMER ADVERTISING; FORECASTING; HUMANS; INTERNET; MARKETING; MASS MEDIA; NEW ZEALAND; RADIO; TELEVISION; UNITED STATES;

EID: 84931047341     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/s12913-015-0885-1     Document Type: Article

References (39)

1. Mackey TK, Liang BA. It's time to shine the light on direct-to-consumer advertising. The Annals of Family Medicine. 2015;13:82-5.
2. Liang BA, Mackey T. Confronting conflict: addressing institutional conflicts of interest in academic medical centers. Am J Law Med. 2010;36:136-87.
3. Gagnon M-A, Lexchin J. The cost of pushing pills: a New estimate of pharmaceutical promotion expenditures in the United States. PLoS Med. 2008;5, e1.
4. Health at a Glance 2011: OECD Indicators [ http://www.oecd.org/els/health-systems/49105858.pdf ]
5. Prescription Drug Trends [ https://kaiserfamilyfoundation.files.wordpress.com/2013/01/3057-08.pdf ]
6. Mackey T, Liang B. Globalization, evolution and emergence of direct-to-consumer advertising: are emerging markets the next pharmaceutical marketing frontier. J Commer Biotechnol. 2012;18:58-64.
7. Palumbo FB, Mullins CD. The development of direct-to-consumer prescription drug advertising regulation. Food Drug Law J. 2002;57:423-43.
8. Wang B, Kesselheim AS. The role of direct-to-consumer pharmaceutical advertising in patient consumerism... virtual mentor. Virtual Mentor. 2013;15:960-5.
9. Liang BA, Mackey TK. Prevalence and global health implications of social media in direct-to-consumer drug advertising. J Med Internet Res. 2011;13, e64.
10. Liang BA, Mackey T. Direct-to-consumer advertising with interactive internet media: global regulation and public health issues. JAMA. 2011;305:824-5.
11. Velo G, Moretti U. Direct-to-consumer information in Europe: the blurred margin between promotion and information. Br J Clin Pharmacol. 2008;66:626-8.
12. Liang BA, Mackey T. Reforming direct-to-consumer advertising. Nature Rev Drug Discovery. 2011;29:397-400.
13. Ventola CLC. Direct-to-consumer pharmaceutical advertising: therapeutic or toxic? P T. 2011;36:669-84.
14. Stange KC. Time to Ban direct-to-consumer prescription drug marketing. The Annals of Family Medicine. 2007;5:101-4.
15. Frosch DL, Grande D, Tarn DM, Kravitz RL. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising. American Journal of Public Health. 2009;100:24-32.
16. Ross JS, Kravitz RL. Direct-to-consumer television advertising: time to turn off the tube? J Gen Intern Med. 2013;28:862-4.
17. Lyles A. Direct marketing of pharmaceuticals to consumers. Annu Rev Public Health. 2002;23:73-91.
18. Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, et al. Information from pharmaceutical companies and the quality, quantity, and cost of Physicians' prescribing: a systematic review. PLoS Med. 2010;7, e1000352.
19. Ethical criteria for medicinal drug promotion [ http://apps.who.int/medicinedocs/documents/whozip08e/whozip08e.pdf ]
20. Kornfield R, Donohue J, Berndt ER, Alexander GC. Promotion of prescription drugs to consumers and providers, 2001-2010. PLoS ONE. 2013;8, e55504.
21. Zachry III WM, Dalen JE, Jackson TR. Clinicians' responses to direct-to-consumer advertising of prescription medications. Arch Intern Med. 2003;163:1808-12.
22. Harrison C. The patent cliff steepens. Nat Rev Drug Discov 2011, 10:12-13.
23. Pew Internet: Health [ http://www.pewinternet.org/fact-sheets/health-fact-sheet/ ]
24. Greene JA, Kesselheim AS. Pharmaceutical marketing and the new social media. N Engl J Med. 2010;363:2087-9.
25. Mackey TK, Liang BA. Global reach of direct-to-consumer advertising using social media for illicit online drug sales. J Med Internet Res. 2013;15, e105.
26. Mintzes B, Morgan S, Wright JM. Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale. PLoS ONE. 2009;4, e5699.
27. Toop L, Richards D, Saunders B. New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit? N Z Med J. 2003;116:U556.
28. Hoffman JR, Cooper RJ. Efforts to ban direct-to-consumer advertising in New Zealand: a call to action. Br J Gen Pract. 2003;53:267-9.
29. Social Media Guidance Webinar - July 10, 2014 [ http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/UCM404562.pdf ]
30. Pharmaceuticals decry FDA's social media rules [ http://thehill.com/regulation/218700-pharmaceutical-companies-decry-fdas-social-media-rules ]
31. Mackey TK, Liang BA. Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health. Global Health. 2013;9:45.
32. Orizio G, Rubinelli S, Schulz PJ, Domenighini S, Bressanelli M, Caimi L, et al. "Save 30 % if you buy today". Online pharmacies and the enhancement of peripheral thinking in consumers. Pharmacoepidemiol Drug Saf. 2010;19:970-6.
33. Siva N. Search engines continue to advertise rogue online pharmacies. BMJ. 2009;339:b3457-7.
34. Jena AB, Goldman DP, Foster SE, Califano JA. Growing internet use may help explain the rise in prescription drug abuse in the United States. Health Aff (Millwood). 2011;155:1192-9.
35. Liang BA, Mackey T. Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales. Am J Law Med. 2009;35:125-84.
36. Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J, et al. How to achieve international action on falsified and substandard medicines. BMJ. 2012;345:e7381.
37. Mackey TK, Liang BA. Physician payment disclosure under health care reform: will the sun shine? J Am Board Fam Med. 2013;26:327-31.
38. Steinbrook R. Disclosure of industry payments to physicians. N Engl J Med. 2008;359:559-61.
39. Mackey TK, Liang BA, Kohler JC, Attaran A. Health domains for sale: the need for global health internet governance. J Med Internet Res. 2014;16, e62.